利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

25 条记录 (耗时 0.031 秒)

    Indanylamino uracils and their use as antioxidants and neuroprotectants
    9.
    发明申请
    Indanylamino uracils and their use as antioxidants and neuroprotectants 审中-公开
    茚基氨基尿嘧啶及其作为抗氧化剂和神经保护剂的用途

    公开(公告)号：US20070021450A1

    公开(公告)日：2007-01-25

    申请号：US11182452

    申请日：2005-07-15

    申请人： Benjamin Sklarz ,  Eliezer Falb ,  Gyorgy Toth ,  Yaacov Herzig ,  Jeffrey Sterling

    发明人： Benjamin Sklarz ,  Eliezer Falb ,  Gyorgy Toth ,  Yaacov Herzig ,  Jeffrey Sterling

    IPC分类号： A61K31/513 ,  C07D239/545

    CPC分类号： C07D239/545

    摘要： Disclosed are compounds having the structure: wherein, R1 is H, NH2, NH—(C1-C4)alkyl, or N—[(C1-C4)alkyl]2; R2 and R3 are each independently H, (C1-C4)alkyl, or wherein R4 is H, (C1-C4)alkyl, halogen, hydroxy, (C1-C10)alkoxy, cyano, nitro, —NR5R6, or —OCONR7R8; wherein R5 and R6 are each independently H, or a substituted or unsubstituted (C1-C4)alkyl; and wherein R7 and R8 are each independently H, or substituted or unsubstituted (C1-C4)alkyl, or (C1-C10)aryl; and wherein only one of R2 and R3 is H, enantiomers, tautomers, and pharmaceutically acceptable salts of the compounds, pharmaceutical compositions containing such compounds or salts, and processes for their preparation. The subject invention also provides methods of alleviating symptoms of neurologic and inflammatory disorders, methods of preventing oxidation of lipids, proteins, or deoxyribonucleic acids on a cellular level, and methods of protecting human red blood cells from lysis by O2 radicals.

    摘要翻译： 公开了具有以下结构的化合物：其中R 1是H，NH 2，NH-（C 1 -C 4） 或N - [（C 1 -C 4）烷基]亚烷基;或N - [（C 1 -C 4 - R 2和R 3各自独立地为H，（C 1 -C 4 -C 4）烷基，或其中R （C 1 -C 4）烷基，卤素，羟基，（C 1 -C 4）烷基， 烷氧基，氰基，硝基，-NR 5 R 6或-CONR 7 R 13， 8

    Diamino thiazoloindan derivatives and their use
    10.
    发明申请
    Diamino thiazoloindan derivatives and their use 审中-公开
    二氨基噻唑烷衍生物及其用途

    公开(公告)号：US20050197365A1

    公开(公告)日：2005-09-08

    申请号：US11067110

    申请日：2005-02-25

    申请人： Jeffrey Sterling ,  Liat Hayardeny-Nisimov ,  David Lerner ,  Yaacov Herzig ,  Eliezer Falb ,  Gyorgy Toth ,  Sandor Molnar ,  Dalia Pinkert

    发明人： Jeffrey Sterling ,  Liat Hayardeny-Nisimov ,  David Lerner ,  Yaacov Herzig ,  Eliezer Falb ,  Gyorgy Toth ,  Sandor Molnar ,  Dalia Pinkert

    IPC分类号： A61K31/428 ,  C07D277/84

    CPC分类号： A61K31/428 ,  C07C211/42 ,  C07C211/60 ,  C07C233/14 ,  C07C233/41 ,  C07C271/24 ,  C07C2602/08 ,  C07D277/60

    摘要： The subject invention provides a compound having the structure: wherein Y is O, NR3R4 or NOR6; R3 is H, alkyl, aralkyl, alkynyl, trifluoroacetyl, t-butoxycarbonyl or an acyl group; R4 is H, alkyl, aralkyl, or alkynyl; R6 is H or C1-C4 alkyl; R1 and R2 are each independently H, alkyl, aralkyl, or alkynyl; the curved line drawn from S to the center of the phenyl ring and the straight line drawn from N to the center of the ring indicate that S and N are part of a 5 membered ring which shares two carbons with the phenyl ring; and the dashed line drawn from the carbon atom on the cyclopentyl ring to Y represents a bond when Y is O or NOR6 and is absent when Y is NR3R4, and wherein wherein X is H or O; and R5 is H, alkyl, trifluoroacetyl, t-butoxycarbonyl or an acyl group, or an enantiomer, or a tautomer, or a pharmaceutically acceptable salt thereof, a process for preparing the compounds and a method of treating Parknison's disease, multiple sclerosis or depression with the compounds of the invention.

    摘要翻译： 本发明提供具有以下结构的化合物：其中Y为O，NR 3 R 4或NOR 6; R 3是H，烷基，芳烷基，炔基，三氟乙酰基，叔丁氧基羰基或酰基; R 4是H，烷基，芳烷基或炔基; R 6是H或C 1 -C 4烷基; R 1和R 2各自独立地为H，烷基，芳烷基或炔基; 从S到苯环中心的曲线和从N到环的中心的直线表示S和N是与苯环共享两个碳的5元环的一部分; 在Y为O或NOR 6时，从环戊基环上的碳原子取代的虚线表示Y，当Y为NR 3 R时，不存在 > 4，并且其中X是H或O; R 5是H，烷基，三氟乙酰基，叔丁氧基羰基或酰基，或其对映体或其互变异构体或其药学上可接受的盐，该化合物的制备方法和 用本发明的化合物治疗帕金森病，多发性硬化或抑郁症。